1-3 of 3
Giada Licata
Close
Sort by
Journal Articles

Clinical Relevance of the Dose of Cytarabine In the Treatment of Primary CNS Lymphomas with Methotrexate-Cytarabine Chemotherapy Combination

AndreĢs JM Ferreri, MD, Giada Licata, Marco Foppoli, Gaetano Corazzelli, Emanuele Zucca, Caterina Stelitano, Francesco Zaja, Sergio Fava, Rossella Paolini, Alberto Franzin, Letterio Politi, Maurilio Ponzoni, MD, Michele Reni
Journal: Blood
Blood (2010) 116 (21): 1780.
https://doi.org/10.1182/blood.V116.21.1780.1780
Published: 2010
Journal Articles

Post-Chemotherapy Brain Irradiation in Primary CNS Lymphomas: Impact on Survival of Different Fields and Doses.

Andres JM Ferreri, Chiara Verona, Letterio Salvatore Politi, Lucia Perna, Anna Chiara, Marco Foppoli, Giada Licata, Silvia Mappa, Fabio Ciceri, Piero Picozzi, Alberto Franzin, Silvia Govi, Maurilio Ponzoni, MD, Maria Rosa Terreni, Eugenio Villa, Michele Reni, M.D.
Journal: Blood
Blood (2009) 114 (22): 2696.
https://doi.org/10.1182/blood.V114.22.2696.2696
Published: 2009
Journal Articles

A Six-Month Regimen of Oral Clarithromycin Is a Feasible and Active Therapy for Patients with Relapsed/Refractory Marginal Zone B-Cell Lymphoma of MALT-Type

Andres JM Ferreri, MD, Giuseppina Patrizia Dognini, M.D., Roberto Crocchiolo, M.D., Silvia Govi, M.D., Giada Licata, M.D., Maurilio Ponzoni, M.D., Antonio Giordano Resti, M.D., Letterio Salvatore Politi, M.D., Alberto Rosso, M.D., Eugenio Villa, M.D.
Journal: Blood
Blood (2008) 112 (11): 3062.
https://doi.org/10.1182/blood.V112.11.3062.3062
Published: 2008